Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Nov 19, 2026 >>   ABB 6958.45 [ 1.88 ]ACC 1268.25 [ 3.11 ]AMBUJA CEM 397 [ 3.22 ]ASIAN PAINTS 2593.8 [ 0.41 ]AXIS BANK 1418 [ 4.38 ]BAJAJ AUTO 10815 [ 2.32 ]BANKOFBARODA 285.5 [ 4.16 ]BHARTI AIRTE 2147.2 [ 0.81 ]BHEL 434 [ 3.12 ]BPCL 307.5 [ 0.82 ]BRITANIAINDS 4869.75 [ 4.05 ]CIPLA 1416 [ -0.28 ]COAL INDIA 392 [ 0.90 ]COLGATEPALMO 1775 [ 4.41 ]DABUR INDIA 391 [ 2.89 ]DLF 767.1 [ 0.14 ]DRREDDYSLAB 1398 [ 0.14 ]GAIL 191.85 [ 1.05 ]GRASIM INDS 3104.7 [ 0.93 ]HCLTECHNOLOG 1331.6 [ -1.10 ]HDFC BANK 820.5 [ 1.58 ]HEROMOTOCORP 5556 [ 5.83 ]HIND.UNILEV 2073.9 [ 4.22 ]HINDALCO 909 [ 0.96 ]ICICI BANK 1605.4 [ 0.34 ]INDIANHOTELS 891.75 [ 1.97 ]INDUSINDBANK 923 [ 1.21 ]INFOSYS 1090.55 [ -1.66 ]ITC LTD 301 [ 1.35 ]JINDALSTLPOW 1078.9 [ -2.39 ]KOTAK BANK 500.6 [ 1.15 ]L&T 4205 [ 1.28 ]LUPIN 1999 [ 1.53 ]MAH&MAH 3510.2 [ 4.78 ]MARUTI SUZUK 13599 [ 7.58 ]MTNL 24.82 [ -1.15 ]NESTLE 1305.4 [ 1.67 ]NIIT 70.15 [ 1.07 ]NMDC 68.21 [ -0.13 ]NTPC 325 [ 1.56 ]ONGC 224.5 [ -0.16 ]PNB 155.4 [ 3.77 ]POWER GRID 264 [ 1.93 ]RIL 1370 [ 0.59 ]SBI 1158 [ 2.11 ]SESA GOA 243.4 [ -0.90 ]SHIPPINGCORP 249.55 [ -2.63 ]SUNPHRMINDS 1903 [ 1.64 ]TATA CHEM 649.8 [ 2.38 ]TATA GLOBAL 1141.5 [ 1.20 ]TATA MOTORS 263.3 [ 4.07 ]TATA STEEL 180.8 [ 1.12 ]TATAPOWERCOM 340 [ 0.56 ]TCS 2346.6 [ -1.41 ]TECH MAHINDR 1723 [ -1.38 ]ULTRATECHCEM 12580 [ 1.36 ]UNITED SPIRI 1465 [ 2.23 ]WIPRO 184.4 [ -0.59 ]ZEETELEFILMS 71.45 [ 0.98 ] BSE NSE
You can view full text of the latest Director's Report for the company.

BSE: 544476ISIN: INE0J5801029INDUSTRY: Pharmaceuticals

BSE   ` 302.85   Open: 297.90   Today's Range 297.05
314.05
+7.15 (+ 2.36 %) Prev Close: 295.70 52 Week Range 277.00
809.45
Year End :2026-03 

Your Directors have pleasure in presenting the 9th Annual Report on the business and operations of the Company, together
with the audited standalone and consolidated financial statements for the financial year ended March 31, 2026 ("FY 2025-26").

FINANCIAL RESULTS

A summary of standalone and consolidated financial results of the Company for the Financial Year 2025-26 and Financial Year
2024-25 is as follows:

Particulars

Standalone

Consolidated

FY 2025-2026

FY 2024-2025

FY 2025-2026

FY 2024-2025

Revenue from Operations

80,134.64

46,907.19

80,136.39

46,907.19

Other Income

865.89

673.54

849.61

673.54

Total Income

81,000.53

47,580.73

80,986.00

47,580.73

Less: Expenses

Cost of material consumed

-

-

-

-

Purchase of Stock in Trade

10,011.39

5,857.99

10,020.21

5,857.99

Changes in Inventories of Stock in Trade

(862.53)

(435.71)

(867.23)

(435.71)

Employee Benefit Expenses

14,840.48

10,074.28

14,840.48

10,074.28

Finance Cost

1,283.35

1,065.49

1,283.35

1,065.49

Depreciation and Amortization Expenses

4,757.82

2,910.54

4,769.20

2,910.54

Other Expenses

21,182.55

17,350.38

21,200.64

17,350.38

Total Expenses

51,213.06

36,822.97

51,246.65

36,822.97

Profit before exceptional and extraordinary
items and tax

29,787.47

10,757.76

29,739.35

10,757.76

Exceptional and Extraordinary items

Profit Before Tax

29,787.47

10,757.76

29,739.35

10,757.76

Tax Expenses

7,569.90

2,763.43

7,569.54

2,763.43

Net Profit for the Year

22,217.57

7,994.33

22,169.81

7,994.33

Total other Comprehensive Income for the
year

22,276.70

7,992.58

22,229.26

7,992.58

FINANCIAL PERFORMANCE
STANDALONE:

During the current period, your company has shown an
increase in total income of 5 81,000.53 Lakhs as against
5 47,580.73 Lakhs in the previous year on standalone
basis. The Company has earned a net profit of 5 22,217.57
Lakhs as compared to a profit of 5 7,994.33 Lakhs in the
previous year on standalone basis. The company will
continue to pursue expansion in the domestic market, to
achieve sustained and profitable growth.

CONSOLIDATED:

During the current period, your company has shown an
increase in total income of 5 80,986.00 Lakhs as against
5 47,580.73 Lakhs in the previous year on consolidated basis.
The Company has earned a net profit of 5 22,169.81 Lakhs as
compared to a profit of 5 7,994.33 Lakhs in the previous year
on consolidated basis. The company will continue to pursue
expansion in the domestic market, to achieve sustained and
profitable growth.

Any member intending to have a copy of Balance Sheet and
other Financial Statement of these Companies shall be made
available on the website of the Company at
www.jeenasikho.
com
.

It shall also be kept for inspection during business hours by
any shareholder in the registered office of the Company.

SHARE CAPITAL
Authorised Share Capital

As on March 31, 2026, the Authorised Share Capital of the
Company stood at 5 25,00,00,000/-(Rupees Twenty-Five
Crores Only) divided into 12,50,00,000 (Twelve Crores Fifty
Lakhs) Equity Shares of 5. 2/- (Rupees Two) each.

During the financial year under review, pursuant to the
approval of the Members through Postal Ballot on May 23,
2025, the Company subdivided its equity shares from 1
(One) equity share of face value E 10/- each into 5 (Five)
equity shares of face value E 2/- each. The Record Date for
the purpose of the sub-division was June 12, 2025.

Consequent to the aforesaid sub-division, the authorised
share capital of the Company was reclassified into equity
shares of face value of 52/- each without any change in the
aggregate amount of the authorised share capital.

Paid Up Share Capital

As on March 31, 2026, the Paid-up Share Capital of the
Company stood at 5. 24,86,01,460/- (Rupees Twenty-
Four Crores Eighty-Six Lakhs One Thousand Four Hundred
and Sixty) divided into 12,43,00,730 (Twelve Crore Forty-
Three Lakh Seven Hundred Thirty) equity shares of 5 2/-
(Rupees Two only) each.

During the financial year under review, pursuant to the
approval of the Members through Postal Ballot on May 23,
2025, the Company subdivided its equity shares from
1 (One) equity share of face value 5 10/- each into 5 (Five)
equity shares of face value 5 2/- each
. The Record Date for
the purpose of the sub-division was June 12, 2025.

Consequent to the sub-division, the number of issued,
subscribed and paid-up equity shares increased
proportionately; however, the aggregate paid-up share
capital of the Company and the percentage shareholding of
each shareholder remained unchanged.

The Company has not issued any shares with differential
voting rights, sweat equity shares or equity shares with
differential rights during the Financial Year 2025-26.

MIGRATION FROM SME PLATFORM TO MAIN
BOARD

Your Company was initially listed on the SME Emerge Platform
of National Stock Exchange of India Limited (NSE) on
19th April,
2022
. During the year under review, with the continued trust
and confidence of our valued shareholders and stakeholders,
your Company successfully migrated to the Main Board of
both
NSE and BSE Limited w.e.f. 11th August, 2025.

The equity shares of the Company are presently listed and
traded on the Main Board of NSE and BSE under the following
details:

• NSE Symbol: JSLL

• BSE Scrip Code: 544476

The migration marks a significant milestone in the Company's
growth journey, reflecting its consistent performance, strong
corporate governance practices, and enhanced credibility
in the capital markets. Listing on the Main Board will provide
wider visibility, increased participation from institutional
investors, enhanced liquidity for the Company's equity shares,
and create greater long-term value for all stakeholders.

The Board places on record its sincere appreciation for the
continuous support extended by shareholders, regulators,
employees, and business partners in achieving this important
step in the Company's growth trajectory.

DEMATERIALISATION OF EQUITY SHARES

All the Equity shares of the Company are in dematerialized
form with either of the depositories viz NSDL and CDSL. The
ISIN No. allotted to the company is
INE0J5801029.

DIVIDEND

Based on the Company's performance during the financial
year 2025-26 and in line with the Dividend Distribution Policy
of the Company, your directors are pleased to recommend a
Dividend of
5 4.50/- per equity share on the face value of
5 2/- each, fully paid-up, for the financial year ended March
31, 2026. The payment of dividend is subject to the approval
of the Members at the ensuing Annual General Meeting
("AGM") and shall be subject to deduction of tax at source,
as applicable.

As per the provisions of Regulation 43A of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015
("SEBI Listing Regulations"), your Company has formulated
a Dividend Distribution Policy. This Policy is available on the
https://jeenasikho.com/wp-content/uploads/2024/07/
Dividend-Distribution-Policy JSLL.pdf

TRANSFER OF UNCLAIMED DIVIDENDS/
SHARES TO INVESTOR EDUCATION &
PROTECTION FUND AUTHORITY

Pursuant to Section 124 of the Companies Act, 2013, read
with Investors Education and Protection Fund Authority
(Accounting, Audit, Transfer and Refund) Rules, 2016, all
unpaid or unclaimed dividends are required to be transferred
by the Company to the Investors Education and Protection
Fund (IEPF) established by the Central Government of India,
after the completion of seven years. Further, all shares in
respect of which dividend has not been paid or claimed for
seven consecutive years or more shall also be required to be
transferred by the Company to the Demat Account of the
IEPF Authority.

There were no unclaimed dividends due for transfer to the
IEPF during the financial year 2025-26.

TRANSFER TO GENERAL RESERVE

The Company has not transferred any amount to General
Reserve during the year. The dividend payment is subject to
approval of the members at the 9th Annual General Meeting,
which will be paid, if declared, to the shareholders within 30
days from the date of declaration.

DEPOSITS

During the year under review, the Company has not accepted
or renewed any deposit from the public/members falling
within the ambit of section 73 or section 74 of the Companies
Act, 2013 and the Companies (Acceptance of Deposits)
Rules, 2014.

CORPORATE GOVERNANCE

The Company's business and operations are managed by
a professional management team of managers led by the
Managing Director, under the supervision and control of the
Board of Directors. The Company maintains and adheres to
the highest standards of corporate governance as stipulated
by the Securities and Exchange Board of India ("SEBI") and
the Companies Act, 2013.

A comprehensive report on Corporate Governance, as
required under Regulation 34 of the SEBI Listing Regulations,
forms part of this Annual Report. A certificate issued by
Mr. Vivek Rawal, Proprietor of M/s Rawal & Co., Practicing
Company Secretary, on compliance with the conditions
of Corporate Governance is annexed as a part of this
Annual Report

MD AND CFO CERTIFICATION

As required by Regulation 17(8) of the SEBI (LODR)
Regulations, 2015, the Managing Director and Chief Financial
Officer of Jeena Sikho Lifecare Limited have furnished the
requisite certificate for the financial year ended March 31,
2026, confirming the accuracy and integrity of the financial
statements and compliance with applicable requirements.

A copy of such certificate forms part of Corporate
Governance Report.

EMPLOYEES STOCK OPTION SCHEMES

Your Company believes in rewarding its employees and
aligning their interests with the long-term objectives of the
organization. Employee Stock Option Schemes form an
integral part of the Company's retention and compensation
strategy, enabling wealth creation opportunities for employees
while ensuring their commitment towards sustained growth.
In line with this philosophy, the shareholders of the Company
approved the "Jeena Sikho Employees Stock Option
Scheme 2024" at the Extraordinary General Meeting held
on
27th February, 2024 and Jeena Sikho Employees Stock
Option Scheme 2025 at the Annual General Meeting held on
29th September, 2025.

Under the said Schemes, the Company grants stock options
on an equity-settled basis, which entitle eligible employees
to purchase one equity share of the Company for each
option granted, at a pre-determined exercise price, upon
completion of the vesting period. The ESOPs thus represent
a call option providing a right, but not an obligation, to the
employees to exercise such options by paying the exercise
price.

During the financial year 2023-24, the Company granted
61,275 options to its employees under Jeena Sikho
Employees Stock Option Scheme 2024. Pursuant to
the corporate action of share split, these options stand
adjusted to
3,06,375 options. No fresh grants were made
under Jeena Sikho Employees Stock Option Scheme 2024
during the Financial Year 2025-26.

During the Financial Year 2025-26, the Company granted
2,18,875 (Two Lakh Eighteen Thousand Eight Hundred
Seventy-Five)
Employee Stock Options to eligible
employees under the Jeena Sikho Employees Stock Option
Scheme, 2025, in accordance with the terms of the Scheme
and the applicable provisions of the Companies Act, 2013
and the Securities and Exchange Board of India (Share Based
Employee Benefits and Sweat Equity) Regulations, 2021.

The applicable disclosures pursuant to Regulation 14 of the
SEBI (Share Based Employee Benefits and Sweat Equity)
Regulations, 2021 and Rule 12(9) of the Companies (Share
Capital and Debentures) Rules, 2014, for the year ended
31st March, 2026 are available on the Company's website at
www.jeenasikho.com.

There has been no material change in the Jeena Sikho
Employees Stock Option Scheme 2024 and Jeena Sikho
Employees Stock Option Scheme 2025 during the year and
the Scheme continues to be in compliance with the aforesaid
SEBI Regulations.

A certificate from the Secretarial Auditors of the Company
confirming that the Scheme has been implemented in
accordance with SEBI (Share Based Employee Benefits and
Sweat Equity) Regulations, 2021 and the resolutions passed

by the Members, is also available on the Company's website
at
www.ieenasikho.com.

SUBSIDIARIES/ASSOCIATES/JOINT VENTURE

During the year under review, the Company expanded its
corporate structure by incorporating its wholly-owned
subsidiary,
Jeena Sikho International LLC, under the
Sharjah Media City (Shams) Free Zone Authority, United
Arab Emirates. The said wholly-owned subsidiary was
successfully incorporated and was granted a business
licence to commence its operations under the name "Jeena
Sikho International LLC" on
11th September, 2025.

Accordingly, as at 31 March 2026, the Company had two
subsidiaries, namely
Jeena Green Resources Private

Limited and Jeena Sikho International LLC, of which Jeena
Sikho International LLC
is a wholly owned subsidiary of
the Company.

The Company did not have any associate company or joint
venture company during the financial year under review.

In accordance with the provisions of Section 129 (3) of the
Act read with the Companies (Accounts) Rules, 2014, a report
on the performance and financial position of each subsidiary
company is provided in the prescribed
Form AOC-1, in
Annexure I to this Report. In accordance with the provisions
of Section 136 of the Act, the Annual Report of the Company,
including the audited standalone and consolidated financial
statements and related information of the Company are
available on the Company's website at
https://ieenasikho.
com/investors.

Further, the audited financial statements of the subsidiary
companies are also available on the website of the Company
at
https://ieenasikho.com/investors.

Further, the Company does not have any Material Subsidiary
within the meaning of the applicable provisions of the
SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended, during the financial year
under review.

The Audit Committee and the Board review the financial
statements and significant transactions of all subsidiary
companies.

BOARD EVALUATION

Pursuant to the provisions of the Act and SEBI Listing
Regulations, the Board of Directors adopted a formal
mechanism for evaluating its performance as well as that
of its committees and individual Directors, including the
Chairperson of the Board. The evaluation was conducted
using a structured questionnaire that covered various
aspects of the functioning of the Board and its Committees.

The Board expressed satisfaction with the overall functioning
of the Board and its Committees based on the evaluation
results.

To familiarize Independent Directors with the Company,
its stakeholders, leadership team, senior management,
operations, policies and industry landscape, a familiarisation
program is conducted. The program aims to provide an
insight and understanding of the Company's business.
Independent Directors are informed about their roles, rights,
and responsibilities through a formal letter of appointment at
the time of their appointment or re-appointment.

Further details regarding the annual evaluation of the
performance of the Board, its Chairperson, its committees
and individual Directors are provided in the Corporate
Governance Report, which forms an integral part of
this Report.

MANAGEMENT DISCUSSION AND ANALYSIS

The Management Discussion and Analysis for the year, as
stipulated under the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (hereinafter referred to as the "SEBI Listing
Regulations"), is presented in a separate section, forms part
of the Annual Report.

DECLARATION OF INDEPENDENCE

Your Company has received declarations from all its
Independent Directors, confirming that they meet the criteria
of independence as prescribed under Section 149(6) of the
Act and Regulation 16(1)(b) of the SEBI Listing Regulations.
These declarations also affirm that there have been no
changes in the circumstances affecting their status as
Independent Directors of the Company.

The Board is of the opinion that the Independent Directors
possess the requisite qualifications, experience, expertise
and proficiency and they uphold the highest standards of
integrity.

DETAILS OF DIRECTORS OR KEY MANAGERIAL
PERSONNEL WHO WERE APPOINTED OR HAVE
RESIGNED DURING THE YEAR

Your Company believes that a strong Board is imperative to
create a culture of leadership to provide a long-term vision
and policy approach to improve the quality of governance.
As on March 31, 2026, the Board of Directors of the Company
consist of optimum combination of Executive Directors and
Independent Directors of the Company.

Director Retiring by Rotation

Pursuant to Section 152 of the Companies Act, 2013, and the
Articles of Association of the Company, Mrs. Bhavna Grover
(DIN: 07557913), Whole Time Director, retires by rotation at
the ensuing AGM of the Company and, being eligible, offers
herself for re-appointment.

Accordingly, a resolution is included in the Notice of the 09th
Annual General Meeting of the Company, seeking approval
of members for her re-appointment as a Director of the
Company.

Changes in the Board During the Financial Year
2025-26, the following changes took place in
the composition of the Board of Directors of the
Company:

• The designation of Ms. Shreya Grover (DIN: 09199495)
was changed from Non-Executive Director to Whole¬
Time Director of the Company for a period of five (5)
years with effect from 27th August, 2025. The said
change was approved by the Board of Directors at its
meeting held on 27th August, 2025 and subsequently
approved by the Members of the Company in the
Annual General Meeting held on 29th September, 2025,
in accordance with the provisions of the Companies
Act, 2013.

• Mrs. Priyanka Bansal (DIN: 09051665) was appointed
as an Additional Director under the category of
Independent Non-Executive Director of the Company
by the Board of Directors with effect from 21st April, 2025
for a first term of five consecutive years commencing
from 21st April, 2025 up to 20th April, 2030 (both days
inclusive).

The appointment of Mrs. Priyanka Bansal as an
Independent Director was subsequently approved by
the Members of the Company through a Postal Ballot
resolution passed on 23rd May, 2025.

Subsequent to the close of the financial year, the Board of
Directors at its meeting held on 15th July, 2026, based on
the recommendation of the Nomination and Remuneration
Committee, approved the following appointments, subject
to the approval of the shareholders wherever applicable:

• Mr. Ajay Sharma (DIN: 07671350) was appointed as an
Additional Director in the category of Non-Executive
Independent Director. Further, his appointment as a
Non-Executive Independent Director, not liable to retire
by rotation, for a term of two (2) consecutive years
commencing from 15th July, 2026 to 14th July, 2028, was
approved, subject to the approval of the shareholders.

• Mrs. Sapna Singh (DIN: 11812894) was appointed as an
Additional Director in the category of Non-Executive
Woman Independent Director. Further, her appointment
as a Non-Executive Independent Director, not liable to
retire by rotation, for a term of two (2) consecutive years
commencing from 15th July, 2026 to 14th July, 2028, was
approved, subject to the approval of the shareholders.

• Dr. Ish Sharma (DIN: 11815526) was appointed as an
Additional Director in the Executive category and
designated as the Whole-Time Director and Key
Managerial Personnel of the Company, liable to retire
by rotation, for a term of two (2) consecutive years
commencing from 15th July, 2026 to 14th July, 2028,
subject to the approval of the shareholders.

• Mr. Ankush Kaushal (DIN: 03308862) was appointed
as an Additional Director in the Executive category
and designated as the Whole-Time Director and Key
Managerial Personnel of the Company, liable to retire
by rotation, for a term of two (2) consecutive years
commencing from 15th July, 2026 to 14th July, 2028,
subject to the approval of the shareholders.

During the Financial Year 2025-26, the following
changes took place in the Key Managerial
Personnels (KMPs) of the Company:

During the year under review, Ms. Anshika Garg resigned from
the position of Company Secretary & Compliance Officer of
the Company with effect from 1st August, 2025.

Subsequently, Mrs. Smita Chaturvedi was appointed as the
Company Secretary & Compliance Officer and designated
as the Key Managerial Personnel of the Company with effect
from 4th August, 2025.

Subsequent to the close of the financial year, Mrs. Smita
Chaturvedi resigned from the position of Company Secretary
& Compliance Officer and Key Managerial Personnel of the
Company with effect from the close of business hours on
14th July, 2026. The Board of Directors, at its meeting held

on 15th July, 2026, approved the appointment of Ms. Priya
Goyal (ACS-71180) as the Company Secretary & Compliance
Officer and designated her as the Key Managerial Personnel
of the Company with effect from 15th July, 2026.

Except as stated above, there were no other changes in the
Key Managerial Personnel of the Company during the year
under review.

Board Composition

As of 31 March 2026, the Company's Board has a strength of
6 (Six) Directors, including 3 (Three) Woman Directors. The
composition of the Board is as below:

Category

Number of
Directors

Executive Director

3 (Three)

Independent Non-Executive Directors

3 (Three)

FAMILIARIZATION PROGRAMME OF
INDEPENDENT DIRECTORS

In compliance with the requirements of the Listing Regulations,
the Company has put in place a familiarization programme
for the Independent Directors to familiarize them with their
roles, rights and responsibilities as Directors, the working of
the Company, nature of the industry in which the Company
operates, business model etc. At the time of appointment/
re-appointment of Independent Directors, a formal letter of
appointment is given to him/her, which, inter-alia, explains
the role, functions, duties and responsibilities expected from
him/her as an Independent Director of the Company. The
Independent Director is also explained in detail the nature,
business model of the industry and compliances under
the Act, the Listing Regulations and other relevant rules &
regulation.

Details of the familiarization programme for Independent
Directors are uploaded on the website of the company at
https://jeenasikho.com/wp-content/uploads/2023/12/
Code-of-Familiarization for Independent
Directors 2025 26.pdf

NOMINATION AND REMUNERATION POLICY

On the recommendation of the Nomination and Remuneration
Committee, the Board has framed a policy for selection and
appointment of Directors, Senior Management including Key
Managerial Personnel and their remuneration. The Nomination
and Remuneration Policy includes the criteria for determining
qualification, positive attributes, independence, etc. is placed
on the website of the Company at
www.jeenasikho.com/
policies
.

The salient features of the Nomination and Remuneration
Policy are mentioned below: 1

• The Committee shall comprise at least three (3)
Directors, all of whom shall be non-executive Directors
and at least two-third shall be Independent.

• Quorum of the meeting shall be either two members or
one-third of the members of the committee, whichever
is greater, including at least one independent director in
attendance.

• The Role of the Committee includes: Periodically
reviewing the size and composition of the Board to
have an appropriate mix of executive and independent
Directors to maintain its independence and separate
its functions of governance and management and
to ensure that it is structured to make appropriate
decisions, with a variety of perspectives and skills, in the
best interests of the Company;

• Formulate the criteria for determining qualifications,
positive attributes and independence of a Director and
recommend to the Board, relating to the remuneration
for the Director, key managerial personnel and other
employees.

• Establishing and reviewing Board, KMP and Senior
Management succession plans in order to ensure and
maintain an appropriate balance of skills, experience
and expertise on the Board and Senior Management.

• The Board as per the criteria approved by the Nomination
and Remuneration Committee shall carry out evaluation
of performance of its own, its committees, and individual
Directors and the Chairman.

VIGIL MECHANISM/WHISTLE BLOWER POLICY:

Pursuant to the provisions of Section 177(9) & (10) of the
Companies Act, 2013, a Vigil Mechanism/Whistle Blower Policy
for directors and employees to report their genuine concerns
has been established. The Vigil Mechanism/Whistle Blower
Policy has been uploaded on the website of the Company
at
https://ieenasikho.com/wp-content/uploads/2023/12/
Whistle-Blower-Policy-1.pdf under 'Investor Section'.

The Policy is an extension of the Code of Conduct for
Directors & Senior Management Personnel and covers any
unethical and improper actions or malpractices and events
which have taken place/suspected to take place.

As per the policy all Protected Disclosures should be
addressed to the Vigilance Officer/Company Secretary
or to the Chairman of the Audit Committee in exceptional
cases.

RISK MANAGEMENT POLICY

The Company has in place a mechanism to identify, assess,
monitor and mitigate various risks to key business objectives.
Major risks identified by the businesses and functions are
systematically addressed through mitigating actions on a
continuing basis. Major elements of risk/threats for Ayurveda
Industry are regulatory concerns, consumer perceptions and
competition. These are discussed at the meetings of the
Audit Committee and the Board of Directors of the Company.
The Board of Directors has adopted a risk management policy
for the company outlining the parameters of identification,
assessment, monitoring and mitigation of various risks

which is available on the website of the company athttps://
ieenasikho.com/wp-content/uploads/2023/12/5.-JSLL
Risk Management Policy.pdf

COMMITTEES OF THE BOARD

The Committees of the Board focus on certain specific areas
and make informed decisions in line with the delegated
authority.

The following Committees constituted by the Board function
according to their respective roles and defined scope:

1. Audit Committee

2. Nomination and Remuneration Committee

3. Stakeholder Relationship Committee

4. Corporate Social Responsibility Committee

5. Risk Management Committee

During the year under review, all recommendations made
by the various committees of the Board have been duly
accepted by the Board.

The Composition of the said Committees are as
under:

Audit Committee:

As on date, the Audit Committee comprises of:

Name of
Director

Designation of
Committee

Nature of
Directorship

Mrs. Priyanka

Chairperson

Independent

Bansal1

Director

Mr. Karan Vir

Member

Independent

Bindra

Director

Mr. Manish Grover

Member

Managing

Director

*Mrs. Priyanka Bansal was appointed as the chairperson of the Committee w.e.f.
October 06, 2025 pursuant to Reconstitution of the Audit Committee.

Company Secretary and Compliance officer will act as the
secretary of the Committee.

Nomination and Remuneration Committee:

As on date the Nomination and Remuneration Committee
comprises of:

Name of

Designation of

Nature of

Director

Committee

Directorship

Mr. Karan Vir

Chairperson

Independent

Bindra

Director

Mr. Chandan

Member

Independent

Kumar Kaushal

Director

Mrs. Priyanka

Member

Independent

Bansal1

Director

Mrs. Priyanka Bansal was appointed as the member of the Committee
w.e.f. August 27, 2025 pursuant to Reconstitution of the Nomination and
Remuneration Committee.

*Ms. Shreya Grover ceased to be a member of the Committee w.e.f. August
27, 2025 pursuant to Reconstitution of the Nomination and Remuneration
Committee.

Company Secretary and Compliance officer will act as the
secretary of the Committee.

Stakeholders' Relationship Committee:

As on date the Stakeholders' Relationship Committee
comprises of:

Name of

Designation of

Nature of

Director

Committee

Directorship

Mr. Chandan

Chairperson

Independent

Kumar Kaushal

Director

Mrs. Bhavna

Member

Whole Time

Grover

Director

Mr. Manish Grover

Member

Managing Director

There is no change in the composition of Stakeholders'
Relationship Committee during the financial year under
review.

Company Secretary and Compliance officer will act as the
secretary of the Committee.

Corporate Social Responsibility Committee:

As on date CSR committee comprises of:

Name

Designation

Nature of
Directorship

Mr. Karan Vir Bindra

Chairman

Independent

Director

Mr. Manish Grover

Member

Managing Director

Mrs. Bhavna Grover

Member

Whole Time Director

There is no change in the composition of Corporate Social
Responsibility Committee during the financial year under
review.

Company Secretary and Compliance officer will act as the
secretary of the Committee.

Risk Management Committee:

As on date Risk Management committee comprises of:

Name

Designation

Nature of
Directorship

Mr. Manish Grover

Chairman

Managing Director

Mrs. Bhavna Grover

Member

Whole Time Director

Mrs. Priyanka

Member

Independent

Bansal

Director

There is no change in the composition of Risk Management
committee during the financial year under review.

Company Secretary and Compliance officer will act as the
secretary of the Committee.

CODE OF CONDUCT

The Board has laid down a Code of Conduct for all Board
members and Senior Management Personnel of the Company.
The Code is displayed on the website of the Company
https://
ieenasikho.com/wp-content/uploads/2023/12/1.-JSLL
Code of Conduct Board Senior Management Final.pdf.
All Board members and Senior Management Personnel have
affirmed compliance with the said Code of Ethics & Conduct.

STATUTORY AUDITORS & AUDITOR'S REPORT

M/s. KRA & Co., Chartered Accountants (Firm Registration
No. 020266N), tendered their resignation as the Statutory
Auditors of the Company vide resignation letter dated
13th August, 2025, effective from 14th August, 2025, after
completion of the Limited Review of the financial results of
the Company for the quarter ended 30th June, 2025. The
Board of Directors placed on record its appreciation for the
professional services rendered by the firm during its tenure
as Statutory Auditors of the Company.

Pursuant to the provisions of Sections 139, 140 and other
applicable provisions of the Companies Act, 2013 read with
the Companies (Audit and Auditors) Rules, 2014, and based
on the recommendation of the Audit Committee, the Board
of Directors appointed M/s. Walker Chandiok & Co LLP,
Chartered Accountants (Firm Registration No. 001076N/
N500013), as the Statutory Auditors of the Company to fill
the casual vacancy caused by the resignation of M/s. KRA &
Co., with effect from 14th August, 2025, to hold office until the
conclusion of the ensuing Annual General Meeting.

Further, the Members of the Company at the Annual General
Meeting held on 29th September, 2025 approved the
appointment of M/s. Walker Chandiok & Co LLP, Chartered
Accountants (Firm Registration No. 001076N/N500013),
as the Statutory Auditors of the Company for a term of five
(5) consecutive years, commencing from the conclusion
of the said Annual General Meeting till the conclusion
of the 13th Annual General Meeting of the Company, on
such remuneration as may be determined by the Board of
Directors.

Statutory Auditors' Report

The Statutory Auditors' Report on the Standalone and
Consolidated Financial Statements of the Company for
the financial year ended 31st March, 2026 forms part of this
Annual Report. The Auditors' Report contains an unmodified
opinion on the Standalone and Consolidated Financial
Statements. Except as otherwise stated in the Auditors'
Report attached to this Annual Report, there are no
observations, comments or explanations which require any
further disclosure or comments by the Board of Directors
pursuant to Section 134(3)(f) of the Companies Act, 2013.

Details with respect to frauds reported by
Auditors

During the year, the Statutory Auditors have not reported any
matter under the second proviso of Section 143(12) of the
Companies Act, 2013, and therefore no details are required
to be disclosed under Section 134(3)(ca) of the Companies
Act, 2013.

SECRETARIAL AUDITORS AND THEIR REPORT

Pursuant to the provisions of Section 204 of the Companies
Act, 2013 read with Rule 9 of the Companies (Appointment
and Remuneration of Managerial Personnel) Rules, 2014 and
based on the recommendation of the Board of Directors, the
Members of the Company at the Annual General Meeting
held on 29th September, 2025 approved the appointment
of M/s. Ankur Singh & Associates, Company Secretaries
(FRN: S2022DE845000), as the Secretarial Auditors of
the Company for a term of five (5) consecutive years
commencing from Financial Year 2025-26 till Financial Year
2029-30.

The Secretarial Audit Report issued by M/s. Ankur Singh &
Associates, Company Secretaries, in Form MR-3 for the
Financial Year ended 31st March, 2026 is annexed to this
Board's Report as Annexure II.

The Secretarial Compliance Report pursuant to Regulation
24A of SEBI (LODR) Regulations, is annexed as Annexure III,
forming part of this Report.

The Secretarial Auditors have observed that there was a
delay in filing the intimation of the Board Meeting convened
for consideration of the financial results, as required
under Regulations 29(2) and 29(3) of the Securities and
Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015. Consequently, the
Company paid the applicable penalty levied by the Stock
Exchange(s) for the said delay.

Management's Reply: The delay was an isolated procedural
lapse and was neither deliberate nor intended to withhold any
material information from the stakeholders. The Company has
already complied with the applicable regulatory requirements
and paid the prescribed penalty. Further, the Company has
strengthened its internal compliance monitoring mechanism
by implementing enhanced review processes, maintaining
a comprehensive compliance calendar, and instituting
additional levels of oversight to ensure timely regulatory
filings and to prevent recurrence of such instances.

Further, except for the above observation, the Secretarial
Audit Report does not contain any other qualification,
reservation, adverse remark or disclaimer requiring
explanation by the Board. The Secretarial Auditors have also
confirmed that no fraud has been reported under Section
143(12) of the Companies Act, 2013 during the financial year
under review.

COST AUDITORS

The provisions of maintenance of Cost Records as specified
by the Central Government under subsection (1) of Section
148 of the Act are not applicable on the Company.

MEETINGS OF BOARD OF DIRECTORS

During the financial year 2025-2026, your Board of Directors met 17 (Seventeen) times. The details of meeting & attendance
are given hereunder. The intervening gap between the Meetings was within the prescribed period.

Sr.

No.

Date of Board Meeting

No. of Directors eligible
to attend

No. of Directors
attended meeting

1

21-04-2025

5

5

2

30-04-2025

6

6

3

16-05-2025

6

6

4

28-07-2025

6

6

5

04-08-2025

6

6

MEETINGS OF BOARD OF DIRECTORS (Contd.)

Sr.

No.

Date of Board Meeting

No. of Directors eligible
to attend

No. of Directors
attended meeting

6

14-08-2025

6

6

7

27-08-2025

6

6

8

06-10-2025

6

6

9

13-10-2025

6

6

10

06-11-2025

6

6

11

01-12-2025

6

6

12

23-12-2025

6

6

13

13-01-2026

6

6

14

21-01-2026

6

6

15

07-02-2026

6

6

16

24-02-2026

6

6

17

09-03-2026

6

6

MEETING OF INDEPENDENT DIRECTORS

Pursuant to Regulation 25(3) of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 and
Secretarial Standard-1 on Meetings of the Board of Directors
issued by the Institute of Company Secretaries of India, the
Independent Directors of the Company are required to hold
at least one meeting in a financial year and, being a top 1000
listed entity, at least two meetings in a financial year without
the attendance of Non-Independent Directors and members
of the management.

Accordingly, the Independent Directors of the Company held
two (2) separate meetings during the financial year, i.e. on 1st
January 2026 and 7th February 2026 without the presence
of Non-Independent Directors and members of the
management. At these meetings, the Independent Directors
reviewed the performance of the Non-Independent Directors
and the Board as a whole, reviewed the performance of the
Chairman of the Company, taking into account the views of
Executive Directors, and assessed the quality, quantity and
timeliness of the flow of information between the Company's
management and the Board that is necessary for the Board
to effectively and reasonably perform its duties.

ANNUAL RETURN

Pursuant to Section 92(3) read with Section 134(3) (a) of
the Companies Act, 2013, and Companies (Management
and Administration) Rules, 2014, the Annual Return of the
Company containing the particulars as prescribed under
Section 92 of the Companies Act, 2013, in Form MGT-7, is
available on the Company's website at the weblink
https://
ieenasikho.com/annual-return/?page slug=annual-return
.

CORPORATE SOCIAL RESPONSIBILITY

The Company falls under the criteria as mentioned in
section 135 of the Companies Act, 2013 i.e., Corporate Social
Responsibility and accordingly the amount has been spent on
CSR activities in the financial year 2025-2026 to comply with
the requirements of necessary social expenditure which is 5
169.88 Lakhs i.e. (2% of the average net profit of immediate
preceding three (3) financial years). The constitution of CSR
Committee was applicable for FY 2025-26, subsequently

the CSR Committee is formulated and the composition is
also given. The CSR Report is annexed as Annexure IV.

The Board of Directors of your Company has formulated and
adopted a policy on CSR which can be accessed at
https://
ieenasikho.com/wp-content/uploads/2023/12/2.-CSR
Policy.pdf.

The CSR Policy of your Company outlines the Company's
philosophy for undertaking socially useful programs for
welfare and sustainable development of the community at
large as part of its CSR Obligation.

NATURE OF BUSINESS

There has been no change in business of the Company.

Jeena Sikho Lifecare Limited has a diverse portfolio
consisting of a number of brands and sub-brands including
"Shuddhi". The Company offers a variety of Ayurvedic
Products and services through Shuddhi clinics and HIIMS, all
over the Country. The Company has presence across various
channels such as general groceries, chemists, organized retail
and ecommerce.

MANAGEMENT DISCUSSION AND ANALYSIS

Management Discussion and Analysis Report for the year
under review, as stipulated under the SEBI Listing Regulations,
is presented in a separate section and forms an integral part
of this Report.

PARTICULARS OF LOANS, GUARANTEES OR
INVESTMENTS UNDER SECTION 186

The details of loans and Investments and guarantees covered
under the provisions of Section 186 of the Act are given in the
Notes to the Financial Statements forming a part of Annual
Report.

Current borrowings of the company are compliant with
Section 180(1)(c) of the Companies Act, 2013.

PARTICULARS OF CONTRACTS OR
ARRANGEMENTS WITH RELATED PARTIES:

During the year under review, the Company entered into
related party transactions, all of which were on an arm's length
basis. Certain related party transactions were entered into in
the ordinary course of business, while certain transactions
were not in the ordinary course of business and accordingly
were approved by the Board of Directors pursuant to the
provisions of Section 188 of the Companies Act, 2013 and
other applicable provisions, wherever required.

All related party transactions are presented to the Audit
Committee and the Board for their review and approval.
Omnibus approval is obtained before the commencement
of the financial year for transactions which are repetitive in
nature and also for transactions which cannot be foreseen
and accordingly require omnibus approval.

During the year, the Company did not enter into any related
party transactions that had a conflict with the interests of
the Company. Further, none of the related party transactions
entered into by the Company during the year were material in
nature requiring shareholders' approval under the applicable
provisions of the Companies Act, 2013 and the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.

The details of related party transactions as entered into
by the Company are disclosed in the standalone financial
statements of the Company.

Further, pursuant to the provisions of Section 188 of the
Companies Act, 2013, read with the rules framed thereunder,
the disclosure of particulars of contracts/arrangements with
related parties in Form AOC-2 is annexed to this Report as
Annexure V.

In line with the requirements of the applicable laws,
the Company has formulated a policy on related party
transactions which is uploaded on the website of the
Company at:
https://jeenasikho.com/wp-content/

uploads/2025/05/Revised-RPT JSLL-1.pdf.

DISCLOSURE UNDER THE SEXUAL
HARASSMENT OF WOMEN AT WORKPLACE
(PREVENTION, PROHIBITION AND REDRESSAL)
ACT, 2013

The Company has zero tolerance towards sexual harassment
at the workplace and has adopted a policy on prevention,
prohibition and redressal of sexual harassment at workplace
in line with the provisions of the Sexual Harassment of
Women at Workplace (Prevention, Prohibition and Redressal)
Act, 2013 and the Rules thereunder. As required under law, an
Internal Committee has been constituted for reporting and
conducting inquiry into the complaints made by the victim
on the harassments at the workplace.

During the year under review, the Company has not received
any sexual harassment complaints during the financial year
nor any complaint is pending at the end of the financial year.

The Policy for Prevention of Sexual Harassment of the
Company is available on the Company's website at the web
link
https://ieenasikho.com/investors.

SIGNIFICANT AND MATERIAL ORDERS
PASSED BY THE REGULATORS OR COURTS
OR TRIBUNALS IMPACTING THE GOING
CONCERNS STATUS AND COMPANY'S
OPERATIONS IN FUTURE

There is no significant and material order passed by the
regulators or courts or tribunals impacting the going concern
status and the Company's operations in future.

DETAILS OF DIFFERENCE BETWEEN AMOUNT
OF THE VALUATION DONE AT THE TIME OF
ONE-TIME SETTLEMENT AND THE VALUATION
DONE WHILE AVAILING LOANS FROM THE
BANKS OR FINANCIAL INSTITUTIONS

Not Applicable.

MATERIAL CHANGES AND COMMITMENT
AFFECTING THE FINANCIAL POSITION

No material changes or commitments that could affect the
financial position of the Company have occurred between
the end of the financial year and the date of this report.

CONSERVATION OF ENERGY, TECHNOLOGY
ABSORPTION, FOREIGN EXCHANGE EARNINGS
AND OUTGO

Pursuant to provisions of Section 134(3)(m) & Rule 8(3) of
Companies (Accounts) Rules, 2014 the details of energy
conservation, technology absorption and foreign exchange
earnings and outgo have been given in Annexure VI to
this report.

INTERNAL FINANCIAL CONTROLS AND THEIR
ADEQUACY

Our rapid growth, while a matter of great satisfaction,
continues to put pressure on our internal systems and
processes. It is crucial that we ensure these systems continue
to keep up with our business growth and that our policies
remain relevant in the everchanging business landscape.
Information systems are being continuously evaluated and
revamped to provide timely and relevant information to
various stakeholders, equipping them with the necessary
tools to compete in a challenging market and environment.

We recognize the critical role of IT and information systems
in today's world, and we have several dedicated teams
constantly working to enhance and improve these systems
to stay ahead of the rapidly changing environment. The
Company's system of continuous internal audits ensures
that the laid-down processes and practices are followed and
complied with and that quality processes are strictly adhered
to. Financial discipline is emphasized at all levels of the
business and adherence to quality systems and a focus on
customer satisfaction are critical for the Company to retain
and attract customers and business and these are followed
rigorously. At the same time, the company is strengthening its
core business systems to enhance robustness and achieve
uniformity and consistency in practices and processes
across the company.

The Internal Auditors, who function independently Within
the Company, review the adequacy and efficacy of the key
internal controls. The annual audit plan, approved by the Audit
Committee, guides the scope of audit activities. Additionally,
the Company engages professional and reputable audit firms
from time to time to conduct internal audits of the larger and
more critical operations of the Company.

In addition to financial audits, quality management system
procedures are continuously audited by internal and external
auditors to ensure that the Company's business practices
conform to the requirements of customers.

The Directors believe that the Company has in place
adequate internal financial controls with reference to
financial statements. The Company's internal control systems
are commensurate with the nature, size and complexity of
its business and ensure the proper safeguarding of assets,
maintenance of proper accounting records and provision of
reliable financial information. The Internal Audit team of the
Company evaluates the effectiveness and quality of internal
controls and reports on their adequacy through periodic
reporting. During the year under review, these controls were
tested and no reportable material weakness in the design or
operation of such controls was identified.

HUMAN RESOURCES

Your Company treats its "human resources" as one of its
most important assets. Your Company continuously invests
in attraction, retention and development of talent on an
ongoing basis. A number of programs that provide focused
people attention are currently underway. Your Company's
thrust is on the promotion of talent internally through job
rotation and job enlargement.

PARTICULARS OF EMPLOYEES

In terms of the provisions of Section 197 (12) of the Companies
Act, 2013 read with Rule 5 of the Companies (Appointment
and Remuneration of Managerial Personnel) Rules, 2014,
disclosure pertaining to remuneration and other details are
provided in the Annexure VII to this Report.

Particulars of employee remuneration, as required under
Section 197(12) of the Companies Act, 2013 read with
Rule 5(2) and 5(3) of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 forms an
integral part of this Annual Report. In terms of the provisions
of the first proviso to Section 136 (1) of the Companies Act,
2013, the Annual Report is being sent to Members, excluding
the aforementioned information. Any Member interested
in obtaining a copy of such statement may write to the
Company Secretary of the Company at
cs@jeenasikho.com

COMPLIANCE WITH SECRETARIAL
STANDARDS

The Company complies with the applicable Secretarial
Standards issued by the Institute of Company Secretaries
of India and approved by the Central Government under
Section 118(10) of the Companies Act, 2013.

BUSINESS RESPONSIBILITY AND
SUSTAINABILITY REPORT ("BRSR")

Pursuant to Regulation 34(2)(f) of the SEBI Listing
Regulations, a separate section on Business Responsibility
and Sustainability Report, describing the initiatives taken by

the Company from an environmental, social and governance
perspective, forms an integral part of this Report.

Sustainability for your Company is about being responsible
to its various stakeholders and creating shared value for
each of them in a way that reinforces and amplifies our
commitment. Our approach aligns with the ESG framework,
which emphasizes creating economic value in an ecologically
sustainable, socially responsible and governance-driven
manner. We extend our considerations beyond economic
and financial aspects and address our broader role in society
and the communities in which we operate. Consistent efforts
have been made to minimize environmental footprint, reduce
emissions and pollution, and optimize land and water usage.

INDUSTRIAL RELATIONS

The Company maintained healthy, cordial and harmonious
industrial relations at all levels. The enthusiasm and unstinting
efforts of employees have enabled the Company to remain
in the leadership position in the industry. It has taken various
steps to improve productivity across organization.

REGISTRAR AND SHARE TRANSFER AGENT:

During the year under review, Skyline Financial Services Pvt.
Ltd. was the Registrar and Transfer Agent of the Company.

COMPLIANCE WITH THE MATERNITY BENEFIT
ACT, 1961

The Company has complied with the provisions of
the Maternity Benefit Act, 1961, including all applicable
amendments and rules framed thereunder. The Company
is committed to ensuring a safe, inclusive, and supportive
workplace for women employees. All eligible women
employees are provided with maternity benefits as
prescribed under the Maternity Benefit Act, 1961, including
paid maternity leave, nursing breaks, and protection from
dismissal during maternity leave.

The Company also ensures that no discrimination is made
in recruitment or service conditions on the grounds of
maternity. Necessary internal systems and HR policies are in
place to uphold the spirit and letter of the legislation.

DIRECTORS' RESPONSIBILITY STATEMENT

Pursuant to the provisions under Section 134(5) of the Act,
with respect to Directors' Responsibility Statement, the
Directors confirm:

a) That in the preparation of the annual accounts, the
applicable accounting standards have been followed
and no material departures have been made from the
same;

b) That they had selected such accounting policies and
applied them consistently, and made judgements and
estimates that are reasonable and prudent, so as to give
a true and fair view of the state of affai rs of the Company
at the end of the financial year and of the profit and loss
of the Company for that period;

c) That they had taken proper and sufficient care for
the maintenance of adequate accounting records in
accordance with the provisions of the Companies
Act, 2013, for safeguarding the assets of the Company
and for preventing and detecting fraud and other
irregularities;

d) That they had prepared the annual accounts on a going
concern basis;

e) That they had laid down internal financial controls to be
followed by the company and that such internal financial
controls are adequate and were operating effectively;
and

f) That they had devised proper systems to ensure
compliance with the provisions of all applicable laws
and that such systems were adequate and operating
effectively.

OTHER DISCLOSURES

There were no transactions on the following matters during

the year and hence no reporting or disclosure is required:

• Issue of equity shares with differential rights as to
dividend, voting, or otherwise.

• Issue of shares (including sweat equity shares) to
employees of the Company under any scheme save
and except the Employees' Stock Option Scheme
referred to in this Report.

• There is no proceeding pending under the Insolvency
and Bankruptcy Code, 2016.

APPRECIATION

Your directors take this opportunity to thank the customers,
shareholders, suppliers, bankers, business partners/
associates, and Central and State Governments for their
consistent support and encouragement of the Company. We
place on record our appreciation for the contribution made
by our employees at all levels. Our consistent growth was
made possible by their hard work, solidarity, cooperation, and
support.

For and on behalf of Board
Jeena Sikho Lifecare Limited

Sd/-

Bhavna Grover

Whole Time Director
DIN: 07557913

1

The Nomination and Remuneration Policy of the
Company is designed to attract, motivate, improve
productivity and retain manpower by creating a
congenial work environment, encouraging initiatives,
personal growth, team work and inculcating a
sense of belongingness and involvement, besides
offering appropriate remuneration packages and
superannuation benefits.